Nakada Haruka

ナカダハルカ | Nakada Haruka

Affiliation and department：
Job title： Associate Professor

Research field (3)： Healthcare management, medical sociology , Hygiene and public health (non-laboratory) , Hygiene and public health (laboratory)

Research keywords (11)：研究倫理 , 利益相反 , ELSI , Patient and public involvement (PPI) , 臨床試験 , 医療機器 , 人工心臓 , 人工臓器 , 医療倫理 , 公衆衛生 , レギュラトリーサイエンス

Research theme for competitive and other funds (15)：

Show all

Papers (39)：

がん患者の立場からみた全ゲノム解析研究への患者・市民参画の可能性と課題. 2023. 54. 6. 223-231
Haruka Nakada, Saori Watanabe, Kyoko Takashima, Shohei Suzuki, Yuki Kawamura, Yutori Takai, Kenji Matsui, Keiichiro Yamamoto. General public’s understanding of rare diseases and their opinions on medical resource allocation in Japan: a cross-sectional study. Orphanet Journal of Rare Diseases. 2023. 18. 1
Haruka NAKADA, Megumu YOKONO, Akiko NAGAI. Patient and Public Involvement Online in National Whole-genome Sequencing Project in Japan. Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics. 2022. 53. 6. 169-175
Haruka Nakada, Kyoko Takashima, Yuichi Maru, Tsunakuni Ikka, Koichiro Yuji, Sachie Yoshida, Kenji Matsui. Public Attitudes toward COVID-19 Vaccinations before Dawn in Japan: Ethics and Future Perspectives. Asian Bioethics Review. 2022. 14. 3. 287-302
Haruka Nakada, Kelly McBride Folkers, Kyoko Takashima. Comparative Assessment of Non-trial Access to Investigational Medical Products in the U.S. and Japan. Therapeutic Innovation & Regulatory Science. 2021. 55. 2. 401-407

ｍore...

MISC (46)：

中田はる佳. データを2次利用する研究を行う際の個人情報保護と倫理的配慮. 看護研究. 2023. 56. 4. 303-310
中田はる佳, 武藤香織. がん治療の臨床研究に関する患者・市民参画(Patient and Public Involvement:PPI). 癌と化学療法. 2022. 49. 10. 1025-1029
中田はる佳. ロボット介護機器とそれを取り巻く課題. 公衆衛生. 2020. 84. 12. 823-826
中田はる佳, 平沢晃. フィンランドにおけるゲノム情報・医療情報の利活用のための基盤整備. 遺伝子医学. 2020. 10. 3. 151-157
中田はる佳. 臨床研究法が医療機器研究開発に与える影響の検討. 公益財団法人医療機器センター附属医療機器産業研究所リサーチペーパー. 2020. 30

ｍore...

Books (9)：

ｍore...

Lectures and oral presentations (60)：

Public attitudes toward secondary use of patients’ data for purposes beyond individual medical care
(2024)
Situation of PPI in the field of cancer in Japan
(60 th Annual Meeting, European Association for the Study of Diabetes 2024)
What can we learn from research participants’ experiences?
(2024)
Commentary in Pararell Session 6:How to pay for universal access to medicines for rare diseases and by whom? The great conundrum
(WHO Fair Pricing Forum 2024 2024)
PPIと利益相反について考える・その2
(第8回患者・市民参画研究会~みんなのラジオ PPI ~ 2023)

ｍore...

Education (3)：

2012 - 2015 東京大学大学院新領域創成科学研究科メディカルゲノム専攻公共政策研究分野
2004 - 2007 Waseda University Law School
2000 - 2004 The University of Tokyo Faculty of Medicine School of Health Sciences and Nursing

Professional career (2)：

Work history (11)：

2023/10 - 現在 Kanagawa University of Human Services School of Health Innovation Associate Professor
2021/09 - 2023/09 National Cancer Center
2021/04 - 2021/08 National Cancer Center
2019/04 - 2021/03 National Cancer Center
2018/04 - 2019/03 国立がん研究センター研究支援センター生命倫理部COI管理室/社会と健康研究センター生命倫理・医事法研究部研究員

Show all

Committee career (15)：

Show all

Awards (1)：

Association Membership(s) (4)：

THE JAPANESE SOCIETY OF CLINICAL PHARMACOLOGY AND THERAPEUTICS , JAPAN ASSOCIATION FOR BIOETHICS , PPI JAPAN , 日本メディカルAI学会

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page